Search Results

Showing results 1 - 10 of 1942.
Sort By: Date ▼

Stephen Hahn, MD Anderson CMO, confirmed as FDA commissioner

December 13, 2019


The Senate on Thursday voted 72-18 to confirm President Trump's nomination of Stephen Hahn to serve as FDA commissioner.

House approves Pelosi's Rx pricing bill, rejects GOP alternative

December 13, 2019


The House on Thursday voted 230-291 to pass House Speaker Nancy Pelosi's (D-Calif.) bill intended to lower prescription drug prices in the United States, and voted 201-223 to reject a bill introduced by House Republicans that was intended to serve as an alternative to Pelosi's measure.

SCOTUS declines to hear Arizona opioid case against Sackler family

December 13, 2019


The U.S. Supreme Court on Monday declined to hear a rare case brought by Arizona accusing members of the Sackler family, which owns Purdue Pharma, of funneling out billions of dollars from the company before filing for bankruptcy as part of a settlement over its alleged role in the opioid epidemic.

Are these 5 types of medical billing 'fraud by any other name'?

December 13, 2019


Elisabeth Rosenthal, a physician and editor-in-chief of Kaiser Health News, in a New York Times opinion piece recalls her husband's recent experience navigating the U.S. health care system and argues that "[m]uch of what we accept as legal in medical billing would be regarded as fraud in any other sector."

CBO: Pelosi's Rx drug pricing bill would save feds a net $5B—and slow down drug development

December 12, 2019


A provision in House Speaker Nancy Pelosi's (D-Calif.) drug pricing bill that would allow the HHS secretary to negotiate prescription drug prices would save the federal government about $456 billion from 2020-2029, but the bill would raise federal spending in other areas, according a Congressional Budget Office report released Tuesday.

FDA can regulate e-cigarettes, appeals court panel rules

December 12, 2019


An appeals court panel on Tuesday ruled that FDA is able to regulate e-cigarettes just like it does traditional cigarettes, saying the products are "indisputably highly addictive and pose health risks, especially to youth, that are not well understood."

Why drugmakers aren't happy with the US' newly announced trade deal

December 11, 2019


The House Ways and Means Committee on Tuesday announced that Congress and the Trump administration have agreed on a renegotiated North American Free Trade Agreement between the United States, Canada, and Mexico that does not include a 10-year exclusivity period for biologic drugs that was backed by pharmaceutical companies.

Lawmakers could be headed for a showdown on Rx drug prices

December 10, 2019


Leaders on the Senate Finance Committee on Friday unveiled a new, bipartisan bill intended to lower prescription drug prices, and House Republicans on Monday announced a similar bill—both of which clash with a separate proposal introduced earlier this year by House Speaker Nancy Pelosi (D-Calif.).

With opposition from industry, the future of surprise billing legislation remains uncertain

December 10, 2019


The White House on Monday expressed support for a new, bipartisan agreement to address so-called "surprise" medical bills, but the proposal's future is uncertain, as it faces opposition from the provider industry and has yet to receive an endorsement from congressional leadership.

Results Page: [Previous] 1 2 3 4 5  ... [Next]